Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,698	1,829	1,318	1,260	985	1,154
Market Cap Growth	11.14%	38.81%	4.57%	27.92%	-14.60%	-25.58%
Enterprise Value	2,158	2,240	1,629	1,521	1,202	1,377
Last Close Price	707.60	761.13	547.29	522.40	408.39	476.46
PE Ratio	171.17	188.91	144.97	156.37	-	317.23
PS Ratio	7.31	8.34	6.65	6.96	9.95	4.04
PB Ratio	54.58	62.17	56.46	23.92	21.97	19.94
P/TBV Ratio	66.02	62.17	56.46	23.92	21.97	19.94
EV/Sales Ratio	9.30	10.22	8.22	8.40	12.14	4.83
EV/EBITDA Ratio	118.48	122.73	80.79	77.41	-	75.98
EV/EBIT Ratio	174.56	180.50	123.64	102.35	-	119.74
EV/FCF Ratio	-26.20	-	-	-	-	-
Debt / Equity Ratio	15.86	16.22	16.81	6.54	5.35	3.94
Debt / EBITDA Ratio	27.08	25.86	18.95	16.49	-	11.72
Asset Turnover	0.41	0.40	0.39	0.39	0.23	0.69
Inventory Turnover	0.51	0.49	0.49	0.54	0.40	0.88
Quick Ratio	0.39	0.38	0.34	0.29	0.29	0.22
Current Ratio	0.92	0.91	0.88	0.92	0.87	0.89
Return on Equity (ROE)	35.49%	36.70%	23.91%	16.53%	-25.34%	6.29%
Return on Assets (ROA)	1.37%	1.41%	1.62%	2.01%	-1.07%	1.73%
Return on Capital (ROIC)	1.64%	1.68%	2.02%	2.72%	-1.60%	2.55%
Earnings Yield	0.58%	0.53%	0.69%	0.64%	-1.32%	0.32%
FCF Yield	-4.85%	-3.72%	-2.68%	-5.93%	-0.55%	-1.10%
Dividend Yield	0.14%	0.13%	0.27%	0.19%	-	0.31%
Payout Ratio	34.08%	34.91%	11.00%	18.61%	-	81.17%
Total Shareholder Return	0.14%	0.13%	0.27%	0.19%	-	0.31%

Source: S&P Capital IQ. Standard template. Financial Sources.